Report 2 : POINTS TO BE CONSIDERED FOR CONDUCTING TOXICOKINETIC STUDIES UNDER GLP AND FOR VALIDATING ANALYTICAL METHODS (<Session 5A>TOXICOKINETICS)
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 1996-12-20
著者
-
Yuzuriha Teruaki
Pharmaceutical Regulatory Audit & Compliance Department Eisai Co. Ltd.
-
OKADA Junya
Drug Analysis and Pharmacokinetics Research Laboratories, Pharmaceutical Development Division, Taked
-
Okada Junya
Drug Analysis And Pharmacokinetics Research Laboratories Pharmaceutical Development Division Takeda
-
Okada Junya
Drug Analysis And Pharmacokinetics Research Laboratories Takeda Chemical Industries Co. Ltd.
-
Aizawa Kazumasa
Pharmaceutical Research Center Meiji Seika Kaisha Co. Ltd.
関連論文
- Double column-switching high-performance liquid chromatographic method for the determination of TAK-603 and its metabolites in human serum
- Report 2 : POINTS TO BE CONSIDERED FOR CONDUCTING TOXICOKINETIC STUDIES UNDER GLP AND FOR VALIDATING ANALYTICAL METHODS (TOXICOKINETICS)